Gilles Pagès, PhD
Dr. Chief Scientific Officer of Roca Therapeutics / InfAngioPharma
Dr. Gilles Pagès is the chief scientific officer of Roca Therapeutics / InfAngioPharma, a biotechnology company focused on personalized prognosis and therapeutic solutions to cancer. Gilles is the director of
research at French National Institute of Health and Medical Research (INSERM) and consultant for the Scientific Center of Monaco (CSM). Gilles has received several international awards, published 150 papers,
authored 10 patents and participated in three clinical trials. Gilles obtained his PhD in molecular biology from the University of Nice.